KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to -$9.1 billion.

  • Amgen's Enterprise Value rose 2375.34% to -$9.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$9.1 billion, marking a year-over-year increase of 2375.34%. This contributed to the annual value of -$9.1 billion for FY2025, which is 2375.34% up from last year.
  • According to the latest figures from Q4 2025, Amgen's Enterprise Value is -$9.1 billion, which was up 2375.34% from -$9.4 billion recorded in Q3 2025.
  • In the past 5 years, Amgen's Enterprise Value registered a high of -$6.5 billion during Q1 2022, and its lowest value of -$34.7 billion during Q3 2023.
  • Over the past 5 years, Amgen's median Enterprise Value value was -$9.4 billion (recorded in 2022), while the average stood at -$13.1 billion.
  • Per our database at Business Quant, Amgen's Enterprise Value tumbled by 38290.04% in 2023 and then surged by 7406.23% in 2024.
  • Amgen's Enterprise Value (Quarter) stood at -$8.0 billion in 2021, then decreased by 15.78% to -$9.3 billion in 2022, then fell by 17.61% to -$10.9 billion in 2023, then dropped by 9.4% to -$12.0 billion in 2024, then increased by 23.75% to -$9.1 billion in 2025.
  • Its Enterprise Value was -$9.1 billion in Q4 2025, compared to -$9.4 billion in Q3 2025 and -$8.0 billion in Q2 2025.